Chest Pain

1
Pipeline Programs
7
Companies
8
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
1 program
1
Autologous peripheral blood CD34 positive cell therapyPhase 1/21 trial
Active Trials
NCT00221182TerminatedEst. Sep 2009
Roche
RocheSTAVANGER NORWAY, Norway
2 programs
IN-HOspital Program to systematizE Chest Pain Protocol (IN-HOPE)N/A1 trial
The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) StudyN/A
Active Trials
NCT04756362Completed5,497Est. Jul 2022
Abbott
AbbottABBOTT PARK, IL
2 programs
The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) StudyN/A1 trial
blood takingN/A1 trial
Active Trials
NCT03561051Active Not Recruiting700Est. Jan 2025
NCT02789904Completed1,200Est. Nov 2017
Astellas
AstellasChina - Shenyang
1 program
AspirinN/A2 trials
Active Trials
NCT02786979Terminated190Est. Jan 2013
NCT00743197Terminated3Est. May 2010
NK
Nihon KohdenNEW YORK, NY
1 program
Two consecutive 15-lead ECGsN/A1 trial
Active Trials
NCT03426436CompletedEst. Aug 2019
Siemens Healthineers
Siemens HealthineersGermany - Forchheim
1 program
modified HEART scoreN/A1 trial
Active Trials
NCT04904107UnknownEst. Jun 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AstellasAspirin
City TherapeuticsAutologous peripheral blood CD34 positive cell therapy
Siemens Healthineersmodified HEART score
RocheIN-HOspital Program to systematizE Chest Pain Protocol (IN-HOPE)
AbbottThe Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study
Nihon KohdenTwo consecutive 15-lead ECGs
Abbottblood taking
AstellasAspirin

Clinical Trials (8)

Total enrollment: 7,590 patients across 8 trials

NCT02786979AstellasAspirin

Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients

Start: Jul 2010Est. completion: Jan 2013190 patients
Phase 4Terminated
NCT00221182City TherapeuticsAutologous peripheral blood CD34 positive cell therapy

Stem Cell Study for Patients With Heart Disease

Start: Sep 2005Est. completion: Sep 2009
Phase 1/2Terminated
NCT04904107Siemens Healthineersmodified HEART score

Improving the Accuracy of Referrals of Patients With Chest Pain

Start: Jul 2021Est. completion: Jun 2024
N/AUnknown
NCT04756362RocheIN-HOspital Program to systematizE Chest Pain Protocol (IN-HOPE)

IN-HOspital Program to systematizE Chest Pain Protocol (IN-HOPE)

Start: Jul 2020Est. completion: Jul 20225,497 patients
N/ACompleted
NCT03561051AbbottThe Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study

The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study

Start: Oct 2018Est. completion: Jan 2025700 patients
N/AActive Not Recruiting
NCT03426436Nihon KohdenTwo consecutive 15-lead ECGs

Evaluation of Synthesized 18-Lead ECG in the Emergency Department

Start: Feb 2018Est. completion: Aug 2019
N/ACompleted
NCT02789904Abbottblood taking

Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emergency Department

Start: Oct 2015Est. completion: Nov 20171,200 patients
N/ACompleted
NCT00743197AstellasAspirin

Women With Chest Pain and Normal Coronary Arteries Study

Start: May 2008Est. completion: May 20103 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

7 companies competing in this space